LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

Search

Quanterix Corp

Fechado

SetorSaúde

4.4 -2.87

Visão Geral

Variação de preço das ações

24h

Atual

Mín

4.33

Máximo

4.52

Indicadores-chave

By Trading Economics

Rendimento

10M

-23M

Vendas

3.7M

44M

Margem de lucro

-52.712

Funcionários

450

EBITDA

15M

-17M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+65.93% upside

Dividendos

By Dow Jones

Próximos Ganhos

11 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-75M

221M

Abertura anterior

7.27

Fecho anterior

4.4

Sentimento de Notícias

By Acuity

35%

65%

112 / 351 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Neutral Evidence

Quanterix Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

18 de mar. de 2026, 22:51 UTC

Ganhos

AIA Group Value of New Business Rose in 2025, Plans $1.7 Billion New Share Buyback

18 de mar. de 2026, 21:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Constellation Energy to Sell Portfolio of Assets for $5 Billion to Satisfy Regulators

18 de mar. de 2026, 20:31 UTC

Ganhos

Micron 2Q Sales Nearly Triple Amid Tight Memory Supply

18 de mar. de 2026, 23:49 UTC

Conversa de Mercado
Notícias Principais

Nikkei May Fall on Renewed Concerns About Higher Energy Prices -- Market Talk

18 de mar. de 2026, 23:31 UTC

Conversa de Mercado

Gold Rises on Likely Technical Recovery -- Market Talk

18 de mar. de 2026, 22:49 UTC

Conversa de Mercado

New Zealand's Economic Recovery Has Yet to Find Footing -- Market Talk

18 de mar. de 2026, 22:41 UTC

Conversa de Mercado

Woodside Energy Opts for 'Safe, Experienced' Choice as CEO -- Market Talk

18 de mar. de 2026, 22:36 UTC

Ganhos

AIA Group Value of New Business Rose in 2025, Plans $1.7B New Share Buyback

18 de mar. de 2026, 22:24 UTC

Ganhos

AIA Group Announces New Share Buyback of $1.7B >1299.HK

18 de mar. de 2026, 22:23 UTC

Ganhos

AIA Group 2025 Value of New Business Margin Was 58.5%, Up 3.6 Ppt on Year >1299.HK

18 de mar. de 2026, 22:23 UTC

Ganhos

AIA Group 2025 Value of New Business $5.52B Vs. $4.71B >1299.HK

18 de mar. de 2026, 21:58 UTC

Ganhos

Micron Sales Nearly Triple Amid Tight Memory Supply -- Update

18 de mar. de 2026, 21:55 UTC

Conversa de Mercado
Ganhos

Global Equities Roundup: Market Talk

18 de mar. de 2026, 21:55 UTC

Conversa de Mercado
Ganhos

Micron's Phone, PC Business Could Shrink Due to Memory Shortage -- Market Talk

18 de mar. de 2026, 21:40 UTC

Conversa de Mercado

Fuel Price Rise Equates to 20 Bps Rate Hike on Australian Households -- Market Talk

18 de mar. de 2026, 21:16 UTC

Conversa de Mercado

More Procter & Gamble Alumni Join Strobel at Coty -- Market Talk

18 de mar. de 2026, 21:00 UTC

Notícias Principais

Iran War Puts Pressure on Japan's Economy. Takaichi Is In a Bind. -- Barrons.com

18 de mar. de 2026, 20:58 UTC

Ganhos

Micron 2Q Gross Margin Nearly Doubled Due to Higher Pricing, CFO Says

18 de mar. de 2026, 20:41 UTC

Ganhos

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

18 de mar. de 2026, 20:29 UTC

Ganhos

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

18 de mar. de 2026, 20:25 UTC

Ganhos

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

18 de mar. de 2026, 20:17 UTC

Ganhos

These Stocks Are Today's Movers: Micron, Swarmer, Lumentum, Trade Desk, Macy's, Williams-Sonoma, and More -- Barrons.com

18 de mar. de 2026, 20:14 UTC

Conversa de Mercado

Airlines Can't Offset Higher Fuel Prices for Long -- Market Talk

18 de mar. de 2026, 20:09 UTC

Ganhos

Micron Reports Extraordinary Earnings. The Stock Is Up. -- Barrons.com

18 de mar. de 2026, 20:07 UTC

Ganhos

Micron Technology Raises Qtr Dividend to 15c Vs. 11.5c >MU

18 de mar. de 2026, 20:06 UTC

Ganhos

Micron Technology Board Has Approved 30% Increase in Qtrly Div >MU

18 de mar. de 2026, 20:04 UTC

Ganhos

Micron Technology 2Q Operating Cash Flow $11.9 B >MU

18 de mar. de 2026, 20:04 UTC

Ganhos

Micron Technology Sees 3Q Operating Expenses About $1.6 B >MU

18 de mar. de 2026, 20:04 UTC

Ganhos

Micron Technology Sees 3Q Gross Margin About 81% >MU

18 de mar. de 2026, 20:03 UTC

Ganhos

Micron Technology Sees 3Q Adj EPS $19.15 +/- 40c >MU

Comparação entre Pares

Variação de preço

Quanterix Corp Previsão

Preço-alvo

By TipRanks

65.93% parte superior

Previsão para 12 meses

Média 7.5 USD  65.93%

Máximo 8 USD

Mínimo 7 USD

Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para Quanterix Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

2 ratings

0

Comprar

2

Manter

0

Vender

Pontuação Técnica

By Trading Central

5.34 / 6.015Suporte e Resistência

Curto Prazo

Neutral Evidence

Médio Prazo

Bullish Evidence

Longo Prazo

No Evidence

Sentimento

By Acuity

112 / 351 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat